Facing adenocarcinoma of distal esophagus and esophagogastric junction: a CROSS versus FLOT propensity score-matched analysis of oncological outcomes in a high-volume institution-Reference-Cited by-同舟云学术

Facing adenocarcinoma of distal esophagus and esophagogastric junction: a CROSS versus FLOT propensity score-matched analysis of oncological outcomes in a high-volume institution

Published:2023-03-29 Issue:4 Volume:75 Page:921-930
ISSN:2038-131X
Container-title:Updates in Surgery
language:en
Short-container-title:Updates Surg

Author:

Lombardi Pietro Maria,Pansa Andrea^ORCID,Basato Silvia,Giorgi Lorenzo,Perano Vittoria,Marano Salvatore,Castoro Carlo

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s13304-023-01497-5.pdf

Reference31 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

2. Mariette C, Finzi L, Piessen G, van Seuningen I, Triboulet JP (2005) Esophageal carcinoma: Prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg 29:39–45. https://doi.org/10.1007/s00268-004-7542-x

3. Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Corvera C, Das P et al (2019) Esophageal and esophagogastric junction cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 17:855–883. https://doi.org/10.6004/jnccn.2019.0033

4. Popper U, Rumpold H (2021) Update ESMO: gastric and esophageal cancer. Memo Mag Eur Med Oncol 14:180–183. https://doi.org/10.1007/s12254-021-00694-5

5. Nobel T, Molena D (2019) Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma. Ann Gastroenterol Surg 3:390–395. https://doi.org/10.1002/ags3.12268

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of early recurrence of oesophagogastric adenocarcinoma after neoadjuvant FLOT;European Journal of Surgical Oncology;2024-12

2. Prognostic factors in clinicopathology of oesophagogastric adenocarcinoma: a single-centre longitudinal study of 347 cases over a 20-year period;Pathology;2024-06

3. Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma;British Journal of Cancer;2023-10-28

4. Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT;Annals of Surgical Oncology;2023-10-13

5. Chemotherapy is the preferred neoadjuvant treatment of oesophageal adenocarcinoma;British Journal of Surgery;2023-10-05